Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Extensive Stage Lung Small Cell Cancer × selinexor × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 2 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Extensive Stage Lung Small Cell Cancer 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1

Interventions

tislelizumab 1 selinexor 1 atezolizumab 1 anlotinib 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07172412 2025-09-30

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting

Extensive Stage Lung Small Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡